A MODERN VIEW ON THE PROBLEM OF TREATMENT OF UROTHELIAL CANCER
Urothelial cancer (UC) is one of the leading onco-urological diseases. The lack of clinical manifestations of the disease at earlier stages does not allow assigning an adequate therapy in good time. Currently they extensively use conventional methods of treatment, which are constantly improving. Nev...
Main Authors: | S V Salnikova, T A Slavyanskaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Peoples’ Friendship University of Russia (RUDN University)
2018-12-01
|
Series: | RUDN Journal of Medicine |
Subjects: | |
Online Access: | http://journals.rudn.ru/medicine/article/viewFile/20468/16600 |
Similar Items
-
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
by: Katsiaryna Marhelava, et al.
Published: (2019-11-01) -
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
by: Stenehjem DD, et al.
Published: (2018-09-01) -
Novel Experimental Drugs for Treatment of Multiple Myeloma
by: Offidani M, et al.
Published: (2021-03-01) -
Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation
by: Jian-zhou Cao, et al.
Published: (2021-05-01) -
Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin
by: Susanne Deininger, et al.
Published: (2021-06-01)